Paper4097745
Established immunoglobulin producing myeloma (IgE) and lymphoblastoid (IgG) cell lines from an IgE myeloma patient.
Nilsson K and 3 others. Clin Exp Immunol, 1970. Cited by 379 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Established immunoglobulin producing myeloma (IgE) and lymphoblastoid (IgG) cell lines from an IgE myeloma patient. Papers, record 4097745. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4097745
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Established immunoglobulin producing myeloma (IgE) and lymphoblastoid (IgG) cell lines from an IgE myeloma patient.
- PubMed
Connected records3
Records in the library's other databases whose lists name this one, each read from that database's own release: up to 20 of each kind, the most connected first.
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antibody Formation | Major topic |
| Lymphocytes | Major topic |
| Multiple Myeloma | Major topic |
| gamma-Globulins | Major topic |
| Antibody-Producing Cells | |
| Biopsy | |
| Bone Marrow | |
| Bone Marrow Cells | |
| Cell Line | |
| Diploidy | |
| Humans | |
| Immunoglobulin G | |
| Immunoglobulins | |
| Karyotyping | |
| Male | |
| Middle Aged |
Source PubMed
References9
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 6,042,436 | Production of free light chains of immunoglobulin by a hematopoietic cell line derived from a patient with multiple myeloma. | Proc Soc Exp Biol Med | 1967 | https://conductscience.org/library/papers/6042436 | PubMed |
| 2 | 4,168,094 | Immunological studies of an atypical (myeloma) immunoglobulin. | Immunology | 1967 | https://conductscience.org/library/papers/4168094 | PubMed |
| 3 | 4,170,889 | A new class of immunoglobulin in human serum. | Immunology | 1968 | https://conductscience.org/library/papers/4170889 | PubMed |
| 4 | 4,172,053 | Development of immunocytes and immunoglobulin production in long-term cultures from normal and malignant human lymph nodes. | Int J Cancer | 1968 | https://conductscience.org/library/papers/4172053 | PubMed |
| 5 | 5,660,193 | Morphology of cultured hematopoietic cells. | Cancer | 1968 | https://conductscience.org/library/papers/5660193 | PubMed |
| 6 | 5,243,066 | Cell line derived from patient with myeloma. | N Y State J Med | 1968 | https://conductscience.org/library/papers/5243066 | PubMed |
| 7 | 4,181,545 | Isolation and characterization of free gamma chain of immunoglobulin produced by an established cell line of human myeloma cell origin. I. Gamma chain in culture medium. | J Immunol | 1969 | https://conductscience.org/library/papers/4181545 | PubMed |
| 8 | 5,260,617 | Chromosomes and cloning efficiencies of hematopoietic cell lines derived from patients with leukemia, melanoma, myeloma, and Burkitt lymphoma. | J Natl Cancer Inst | 1969 | https://conductscience.org/library/papers/5260617 | PubMed |
| 9 | 4,190,284 | Quantitative immunoglobulin determination. Comparison of two methods. Estimation of normal levels and levels in persons lacking IgA and IgD. | Acta Pathol Microbiol Scand | 1968 | https://conductscience.org/library/papers/4190284 | PubMed |
Cited by94
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 379 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41,917,392 | Glycan Structures of Human Immunoglobulins and Their Roles. | Adv Exp Med Biol | 2026 | https://conductscience.org/library/papers/41917392 | PubMed |
| 41,673,876 | Inhibition of death-ligand-induced apoptosis in Epstein-Barr virus-encoded small RNAs-expressing human T-cell line. | Infect Agent Cancer | 2026 | https://conductscience.org/library/papers/41673876 | PubMed |
| 37,533,642 | TRAPnSeq allows high-throughput profiling of antigen-specific antibody-secreting cells. | Cell Rep Methods | 2023 | https://conductscience.org/library/papers/37533642 | PubMed |
| 36,523,963 | Mutational analysis and protein profiling predict drug sensitivity in multiple myeloma cell lines. | Front Oncol | 2022 | https://conductscience.org/library/papers/36523963 | PubMed |
| 35,960,817 | Immunodeficiency, autoimmunity, and increased risk of B cell malignancy in humans with TRAF3 mutations. | Sci Immunol | 2022 | https://conductscience.org/library/papers/35960817 | PubMed |
| 35,222,411 | Standardization of Workflow and Flow Cytometry Panels for Quantitative Expression Profiling of Surface Antigens on Blood Leukocyte Subsets: An HCDM CDMaps Initiative. | Front Immunol | 2022 | https://conductscience.org/library/papers/35222411 | PubMed |
| 35,148,457 | Ex vivo drug sensitivity screening in multiple myeloma identifies drug combinations that act synergistically. | Mol Oncol | 2022 | https://conductscience.org/library/papers/35148457 | PubMed |
| 34,987,522 | Tracing Human IgE B Cell Antigen Receptor-Bearing Cells With a Monoclonal Anti-Human IgE Antibody That Specifically Recognizes Non-Receptor-Bound IgE. | Front Immunol | 2021 | https://conductscience.org/library/papers/34987522 | PubMed |
| 34,861,096 | Mcl-1 and Bcl-xL levels predict responsiveness to dual MEK/Bcl-2 inhibition in B-cell malignancies. | Mol Oncol | 2022 | https://conductscience.org/library/papers/34861096 | PubMed |
| 34,639,102 | Synergistic Effects of Venetoclax and Daratumumab on Antibody-Dependent Cell-Mediated Natural Killer Cytotoxicity in Multiple Myeloma. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34639102 | PubMed |
| 33,555,379 | Personalized oncology and BRAFK601N melanoma: model development, drug discovery, and clinical correlation. | J Cancer Res Clin Oncol | 2021 | https://conductscience.org/library/papers/33555379 | PubMed |
| 33,469,678 | JMJD2C triggers the growth of multiple myeloma cells via activation of β‑catenin. | Oncol Rep | 2021 | https://conductscience.org/library/papers/33469678 | PubMed |
| 33,397,437 | Targeting phosphoglycerate dehydrogenase in multiple myeloma. | Exp Hematol Oncol | 2021 | https://conductscience.org/library/papers/33397437 | PubMed |
| 33,365,032 | Essentially Leading Antibody Production: An Investigation of Amino Acids, Myeloma, and Natural V-Region Signal Peptides in Producing Pertuzumab and Trastuzumab Variants. | Front Immunol | 2020 | https://conductscience.org/library/papers/33365032 | PubMed |
| 31,972,992 | Rapid Assessment of Functional Avidity of Tumor-Specific T Cell Receptors Using an Antigen-Presenting Tumor Cell Line Electroporated with Full-Length Tumor Antigen mRNA. | Cancers (Basel) | 2020 | https://conductscience.org/library/papers/31972992 | PubMed |
| 29,423,088 | Identification of survivin as a promising target for the immunotherapy of adult B-cell acute lymphoblastic leukemia. | Oncotarget | 2018 | https://conductscience.org/library/papers/29423088 | PubMed |
| 28,782,633 | Plasma cell deficiency in human subjects with heterozygous mutations in Sec61 translocon alpha 1 subunit (SEC61A1). | J Allergy Clin Immunol | 2018 | https://conductscience.org/library/papers/28782633 | PubMed |
| 28,771,465 | EBV epigenetically suppresses the B cell-to-plasma cell differentiation pathway while establishing long-term latency. | PLoS Biol | 2017 | https://conductscience.org/library/papers/28771465 | PubMed |
| 27,981,867 | Phenotypic and functional characterization of a bortezomib-resistant multiple myeloma cell line by flow and mass cytometry. | Leuk Lymphoma | 2017 | https://conductscience.org/library/papers/27981867 | PubMed |
| 27,757,061 | Human iPSC-derived neurons and lymphoblastoid cells for personalized medicine research in neuropsychiatric disorders. | Dialogues Clin Neurosci | 2016 | https://conductscience.org/library/papers/27757061 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/4097745
GET https://conductscience.org/api/papers/v1/4097745/cited_by?page=2